Sahu, Smiti S.Dey, ShatovishaNabinger, Sarah C.Jiang, GuanglongBates, AlisonTanaka, HiromiLiu, YunlongKota, Janaiah2020-01-062020-01-062019-11Sahu, S. S., Dey, S., Nabinger, S. C., Jiang, G., Bates, A., Tanaka, H., … Kota, J. (2019). The Role and Therapeutic Potential of miRNAs in Colorectal Liver Metastasis. Scientific reports, 9(1), 15803. doi:10.1038/s41598-019-52225-2https://hdl.handle.net/1805/21736Colorectal cancer (CRC) is the fourth leading cause of cancer-related deaths worldwide. Liver metastasis is the major cause of CRC patient mortality, occurring in 60% patients with no effective therapies. Although studies have indicated the role of miRNAs in CRC, an in-depth miRNA expression analysis is essential to identify clinically relevant miRNAs and understand their potential in targeting liver metastasis. Here we analyzed miRNA expressions in 405 patient tumors from publicly available colorectal cancer genome sequencing project database. Our analyses showed miR-132, miR-378f, miR-605 and miR-1976 to be the most significantly downregulated miRNAs in primary and CRC liver metastatic tissues, and CRC cell lines. Observations in CRC cell lines indicated that ectopic expressions of miR-378f, -605 and -1976 suppress CRC cell proliferation, anchorage independent growth, metastatic potential, and enhance apoptosis. Consistently, CRC patients with higher miR-378f and miR-1976 levels exhibited better survival. Together, our data suggests an anti-tumorigenic role of these miRNAs in CRC and warrant future in vivo evaluation of the molecules for developing biomarkers or novel therapeutic strategies.en-USColorectal cancerCancer therapyArticle